Related references
Note: Only part of the references are listed.Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders
Mattia Bellan et al.
DISEASE MARKERS (2020)
Association of a Type 2-Polarized T Cell Phenotype With Methotrexate Nonresponse in Patients With Rheumatoid Arthritis
Drew Slauenwhite et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Pulmonary Hypertension Phenotypes in Systemic Sclerosis: The Right Diagnosis for the Right Treatment
Umberto Attanasio et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
ICOS+Tregs: A Functional Subset of Tregs in Immune Diseases
Dan-Yang Li et al.
FRONTIERS IN IMMUNOLOGY (2020)
Red Cell Distribution Width and Platelet Count as Biomarkers of Pulmonary Arterial Hypertension in Patients with Connective Tissue Disorders
Mattia Bellan et al.
DISEASE MARKERS (2019)
The Role of Regulatory T Cells in Pulmonary Arterial Hypertension
Haihua Qiu et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Targeting Costimulatory Pathways in Systemic Sclerosis
Goncalo Boleto et al.
FRONTIERS IN IMMUNOLOGY (2018)
Pulmonary hypertension in connective tissue diseases: an update
Ramya Aithala et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2017)
Mapping and predicting mortality from systemic sclerosis
Muriel Elhai et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Pulmonary sarcoidosis is associated with high-level inducible co-stimulator (ICOS) expression on lung regulatory T cells - possible implications for the ICOS/ICOS-ligand axis in disease course and resolution
P. Sakthivel et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2016)
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2016)
Advances in pathogenesis and treatment of systemic sclerosis
C. P. Denton
CLINICAL MEDICINE (2015)
The Pathogenesis of Systemic Sclerosis
Edward P. Stern et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2015)
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study
J. Gerry Coghlan et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Increased production of soluble inducible costimulator in patients with diffuse cutaneous systemic sclerosis
Koichi Yanaba et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2013)
Recommendations for Screening and Detection of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
Dinesh Khanna et al.
ARTHRITIS AND RHEUMATISM (2013)
Augmented ICOS expression in patients with early diffuse cutaneous systemic sclerosis
Minoru Hasegawa et al.
RHEUMATOLOGY (2013)
Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells
Adrian J. Gilbane et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Screening for Pulmonary Arterial Hypertension in Patients With Systemic Sclerosis Clinical Characteristics at Diagnosis and Long-Term Survival
Marc Humbert et al.
ARTHRITIS AND RHEUMATISM (2011)
Elevated circulating CD4+ICOS+Foxp3+ T cells contribute to overproduction of IL-10 and are correlated with disease severity in patients with systemic lupus erythematosus
Y. Liu et al.
LUPUS (2011)
ICOS: A new costimulatory ligand/receptor pair and its role in T-cell activion
G Richter et al.
ONKOLOGIE (2004)
Share Paper
